| Literature DB >> 29106038 |
Jichao Sun1,2, Subhojit Roy1,2.
Abstract
Alzheimer's disease (AD) is characterized by the accumulation of insoluble deposits of Amyloid β (Aβ) in brains. Aβ is derived by sequential cleavage of the amyloid precursor protein (APP) by β-site secretase enzyme (BACE-1) and γ-secretase. Proteolytic processing of APP by BACE-1 is the rate-limiting step in Aβ production, and this pathway is a prime target for AD drug development. Both APP and BACE-1 are membrane-spanning proteins, transported via secretory and endocytic pathways; and the physical interaction of APP and BACE-1 during trafficking is a key cell biological event initiating the amyloidogenic pathway. Here, we highlight recent research on intracellular trafficking/sorting of APP and BACE-1, and discuss how dysregulation of these pathways might lead to enhanced convergence of APP and BACE-1, and subsequent β-cleavage of APP.Entities:
Keywords: APP; BACE-1; amyloid beta; amyloid precursor protein; endocytosis; fluorescence complementation; protein-protein interaction; trafficking; β-site secretase protein
Mesh:
Substances:
Year: 2017 PMID: 29106038 PMCID: PMC7336871 DOI: 10.1002/dneu.22556
Source DB: PubMed Journal: Dev Neurobiol ISSN: 1932-8451 Impact factor: 3.964